remind 2023 blog header

The reMind 2023 Psychedelics Business Forum: Shaping the Future of Psychedelics

by | Sep 25, 2023

remind 2023 blog header

Written by Jessica McKeil

Jessica McKeil is a cannabis writer and B2B content marketer living in British Columbia, Canada. Her focus on cannabis tech, scientific breakthroughs, and extraction has led to bylines with Cannabis & Tech Today, Terpenes and Testing, Analytical Cannabis, and Grow Mag among others. She is the owner and lead-writer of Sea to Sky Content, which provides content and strategy to the industry’s biggest brands.

Bigger and better than ever, the reMind 2023 Psychedelics Business Forum is back for a second year. This greatly anticipated event, held in collaboration with MJBizCon, promises an even richer experience this year.

Now spanning two days — November 28th and 29th — at the Westgate Las Vegas Resort & Casino, reMind has landed speakers from across the psychedelics spectrum. From Kim Turpin the co-founder of Pearl Psychedelic Institute to Bethany Gomez of Brightfield Group to Joe Moore of Psychedelic Today, the roster is packed.

reMind 2023 offers more exposure, networking, and opportunities to businesses, regulators, healthcare professionals, and investors in the psychedelics space. 

Historic Shift in Psychedelics

The reMind Forum couldn’t come at a better time — a time when the US is experiencing a monumental shift in how we approach psychedelics, medicine, culture, and policy. With dozens of states pursuing policy reforms, a rapidly shifting public perception, and expected approvals from the FDA, this is truly a historic moment. 

Sara Vaughn, VP Brand Leader of reMind, shared in a press release, “As new state-regulated markets come online in Oregon and Colorado, and as similar initiatives gain momentum in dozens of other states, the psychedelics movement is at a historic inflection point. There’s never been a better time for aspiring businesses, mental health practitioners, policymakers, and nonprofits to come together and help steer the future of this critically important industry.” 

A recap of reMind 2022.

Industry Luminaries Converge at reMind 2023

With two star-studded days of speakers, this year’s schedule does not disappoint. You’ll hear from the industry’s most influential change-makers, entrepreneurs, and advocates about the business of psychedelics. 

Think Joe Moore, Co-Founder and CEO of Psychedelics Today; Rebecca Nicholson, CEO & Founding Partner of 5D Ventures; Josh Hardman, Founder of Psychedelic Alpha; Stefany Nieto, Founder & COO, of Gwells/Mojo Microdose; Raad Seraj, Founder of Mission Club; Graham Pechenik, Founder & Registered Patent Attorney at Calyx Law, and too many others to count.

All of them will open up on the main stage to share their knowledge, experiences, and predictions for the industry’s future.

reMind 2023 Session Highlights

Day 1 9:45 – 10:15 AM

A much-needed session with an updated and reconsidered overview of the present psychedelic consumer demographic, delving into generational habits, geographical data, and emerging trends.

Policy Updates and Forecasts: State-Level Initiatives and FDA Approval Pipelines

Day 1 10:30 – 11:00 AM

The topic on the forefront of everyone’s mind: FDA approval of psychedelics. Expect a close examination of the rapidly evolving policy framework around psychedelics, including pathways to legalization and, yes, an update on expected FDA approvals.

Day 2 10:30 – 11:00 AM

Everyone has hoped on the microdose train these days, and there are no signs of it slowing down. This session will demystify the growing interest in botanicals, adaptogens, and microdosing, offering insights into current legal business opportunities. Explore legal business opportunities and prepare for the coming policy changes.

How the Cannabis Industry Can Get Involved: Opportunities in Psychedelics Abound

Day 2 4:00 – 4:40 PM

A session uniquely suited to the Cannabis Tech audience, targeting established businesses in the cannabis sector. Learn how to find potential synergies with the burgeoning psychedelics space. Get advice and insight on expanding into a related market and take your company in new directions.  

The Future of Psychedelics is Here: Will We See You There?

Once again, the reMind Psychedelics Business Forum is set to forge new connections, inspire new policies, and launch new investments in the sector. As the US sits at the cusp of a psychedelic renaissance, reMind is an unparalleled platform for industry leaders, policy shapers, and innovators to share, learn, and collaborate. 

There’s no better moment than now for this convergence of minds. Join the conversation and be part of this groundbreaking movement. Tickets Available Now.